Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Aclarion, Inc. ( (ACON) ) has provided an announcement.
On October 13, 2025, Aclarion, Inc. announced a Securities Purchase Agreement to sell 64,000 shares of its common stock and pre-funded warrants for 236,000 shares in a registered direct offering, expected to close on October 14, 2025. The offering aims to raise approximately $2.5 million, which will be used for market development, clinical evidence, product development, and general corporate purposes, potentially impacting the company’s operational capabilities and market positioning.
The most recent analyst rating on (ACON) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Aclarion, Inc. stock, see the ACON Stock Forecast page.
More about Aclarion, Inc.
Average Trading Volume: 128,262
Technical Sentiment Signal: Sell
Current Market Cap: $5.01M
For detailed information about ACON stock, go to TipRanks’ Stock Analysis page.